Terns Pharmaceuticals

dominoes stop stall halt end red
Biotech

Terns vows to stop funding metabolic disease trials beyond 2025

The plan starts a countdown to potential deals for assets including a midphase oral obesity prospect.
Nick Paul Taylor Aug 6, 2025 6:20am
weight loss scale weigh measure tape obesity overweight

Tern oral GLP-1 shows 5% weight loss at one month, highest dose

Sep 9, 2024 9:13am
parachute sunset paragliding chutes

Takeda taps new head of US oncology business—Chutes & Ladders

Aug 2, 2024 8:30am
leg up help pull climb assist teamwork

Pfizer's obesity pill news leaves analysts wanting

Jul 12, 2024 10:17am
weight loss scale weigh measure tape obesity overweight

Terns' ex-MASH drug cuts fat, not muscle in GLP-1 combo in mice

Jun 25, 2024 8:51am
parachute sun mountain

Sanofi, Pfizer, Acelyrin and more—Chutes & Ladders

May 10, 2024 8:30am